Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Overlapped Compression Therapy

K-Number: K202839 · 2021-01-21

Decision Date2021-01-21
Product CodeJOW
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Overlapped Compression Therapy is a medical device manufactured by Jkh Health Co., Ltd.. It received FDA 510(k) clearance on 2021-01-21 under approval number K202839. The device is classified under product code JOW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Overlapped Compression Therapy?

Overlapped Compression Therapy is a medical device that received FDA 510(k) clearance on 2021-01-21. It is manufactured by Jkh Health Co., Ltd.. The 510(k) number is K202839.

When was Overlapped Compression Therapy approved by the FDA?

Overlapped Compression Therapy received FDA 510(k) clearance on 2021-01-21, under approval number K202839.

What company makes Overlapped Compression Therapy?

Overlapped Compression Therapy is manufactured by Jkh Health Co., Ltd..

What is the FDA product code for Overlapped Compression Therapy?

The FDA product code for Overlapped Compression Therapy is JOW.

Related Clinical Trials

Other Devices by Jkh Health Co., Ltd.

View all 10 devices →

Related Devices (Code: JOW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.